No Data
Yangpu Healthcare: Report for the third quarter of 2024
improve medical instruments (300030.SZ) released performance for the first three quarters, with a net loss of 42.5176 million yuan.
Improve Medical Instruments (300030.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 4...
Improve medical instruments (300030.SZ): a net loss of 42.5176 million yuan in the first three quarters.
Gelonghui on October 25th: improve medical instruments (300030.SZ) released the third quarter report of 2024, achieving revenue of 0.421 billion yuan in the first three quarters, a year-on-year decrease of 10.78%; net income attributable to shareholders of the listed company was -42.5176 million yuan; net profit attributable to shareholders of the listed company excluding non-recurring gains and losses was -13.4899 million yuan; basic earnings per share was -0.14 yuan.
Improve Medical Instruments (SZSE:300030 Shareholders Incur Further Losses as Stock Declines 16% This Week, Taking Three-year Losses to 29%
Improve Medical Instruments (300030.SZ): Currently, the main products are vacuum blood collection systems, not involving foreign medical investment or hospital investment
On September 12th, improve medical instruments (300030.SZ) conducted an investor survey on September 12, 2024, regarding the impact of the current national opening up of foreign medical investment and hospital investment on your company, as well as what development suggestions the main shareholder has. The company stated that its main products are vacuum blood collection systems, which do not involve foreign medical investment or hospital investment.
Improve Medical Instruments Co., Ltd. (SZSE:300030) Shares Fly 46% But Investors Aren't Buying For Growth
Improve Medical Instruments Co., Ltd.'s (SZSE:300030) Shares Bounce 31% But Its Business Still Trails The Industry
